Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

FDA accepts IND application for LY-3561774

Nov. 18, 2020

First-in-human interim results of ALN-AGT01 in patients with hypertension

Nov. 17, 2020

New alpha-2B adrenoceptor antagonists described by Bayer

Nov. 17, 2020

FDA approves Totect to treat cardiomyopathy in women receiving doxorubicin for breast cancer

Nov. 10, 2020

Researchers develop a new Ptpn14-knockout murine model of HHT

Nov. 10, 2020

European Commission approves Forxiga for HFrEF

Nov. 6, 2020

Saillant obtains preclinical proof of concept with ST-02 for heart failure

Nov. 6, 2020

Tenaya Therapeutics presents AAV5 compositions

Nov. 4, 2020

IDMC recommends continuation of phase III trial of REX-001 for diabetic CLI

Oct. 26, 2020

Altered cathepsin K secretion contributes to congenital heart defects in a model of mucolipidosis II

Oct. 23, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...